Connection

Katharine Floyd to Administration, Intranasal

Back to Details
This is a "connection" page, showing publications Katharine Floyd has written about Administration, Intranasal.
Katharine Floyd
Connection Strength
0.040
Administration, Intranasal
  1. A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates. Sci Immunol. 2021 07 15; 6(61).
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.